These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33298560)

  • 1. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
    Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
    Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
    ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
    Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
    J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration.
    Bartra C; Irisarri A; Villoslada A; Corpas R; Aguirre S; García-Lara E; Suñol C; Pallàs M; Griñán-Ferré C; Sanfeliu C
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model.
    Trindade-da-Silva CA; Clemente-Napimoga JT; Abdalla HB; Rosa SM; Ueira-Vieira C; Morisseau C; Verri WA; Montalli VAM; Hammock BD; Napimoga MH
    FASEB J; 2020 Jul; 34(7):9074-9086. PubMed ID: 32400048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
    Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
    Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
    Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
    Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
    CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
    Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
    Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
    Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
    Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
    Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
    Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
    Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
    Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase inhibitor (TPPU) alleviates ferroptosis by regulating CCL5 after intracerebral hemorrhage in mice.
    Wu Q; Jiang N; Wang Y; Song G; Li P; Fang Y; Xu L; Wang W; Xie M
    Biomed Pharmacother; 2024 Mar; 172():116301. PubMed ID: 38377737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
    Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
    Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
    Ma M; Ren Q; Yang J; Zhang K; Xiong Z; Ishima T; Pu Y; Hwang SH; Toyoshima M; Iwayama Y; Hisano Y; Yoshikawa T; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7083-7088. PubMed ID: 30890645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease.
    Lee HT; Lee KI; Chen CH; Lee TS
    J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.